Seattle Science Foundation and ISB

ISB and Seattle Science Foundation Partner to Create Video Series

What are multi-omics? Why does our microbiome matter? What’s the difference between genetics and genomics? What is a digital twin? ISB and Seattle Science Foundation have partnered to create videos answering questions like these and more, showcasing ISB scientists and their work.

ISB and Seattle Science Foundation Partner to Create Video Series
ISB and Seattle Science Foundation Partner to Create Video Series
screenshot of video

Reimagining Chronic Illness: A Conversation With Meghan O’Rourke

Author Meghan O’Rourke recently joined ISB President Dr. Jim Heath for a virtual fireside chat focused on reimagining chronic illness – also the topic of O’Rourke’s New York Times bestselling book. This event was the latest in the ISB-Town Hall Seattle Science Series.

Reimagining Chronic Illness: A Conversation With Meghan O’Rourke
Reimagining Chronic Illness: A Conversation With Meghan O’Rourke
Heath, Allison, Chin

Improving Cancer Care for All: A Conversation with Drs. Jim Heath, Jim Allison and Lynda Chin

ISB President Dr. Jim Heath talks with Nobel laureate and Executive Director of the Immunotherapy Platform at MD Anderson Cancer Center Dr. Jim Allison and Apricity Health CEO Dr. Lynda Chin. Drs. Heath, Allison and Chin discuss disparities in cancer care and ways to bring state-of-the-art care from big cities and major academic centers to rural and underserved areas.

Improving Cancer Care for All: A Conversation with Drs. Jim Heath, Jim Allison and Lynda Chin
Improving Cancer Care for All: A Conversation with Drs. Jim Heath, Jim Allison and Lynda Chin
ISB President Dr. Jim Heath

ISB Leading NCI Comprehensive Cancer Center to Study Sequential Targeted Inhibitors and Immunotherapies

The NCI awarded ISB a 5-year, $13 million grant to lead a comprehensive cancer center and study sequential combinations of targeted inhibitors and immunotherapies. The program is designed to determine if the treatments yield greater patient benefit when administered in sequence rather than as monotherapies or as simultaneously administered combinations.

ISB Leading NCI Comprehensive Cancer Center to Study Sequential Targeted Inhibitors and Immunotherapies
ISB Leading NCI Comprehensive Cancer Center to Study Sequential Targeted Inhibitors and Immunotherapies
screenshot of video thumbnail for Bugs vs. Drugs: How Our Microbiomes Can Explain Our Response to Statins

Bugs vs. Drugs: How Our Microbiomes Can Explain Our Response to Statins

ISB Assistant Professor Dr. Sean Gibbons talked about the science behind statins in our most recent Research Roundtable virtual presentation. His talk was titled “Bugs vs. Drugs: How Our Unique Gut Microbiomes Shape Our Personalized Responses to Statins.”

Bugs vs. Drugs: How Our Microbiomes Can Explain Our Response to Statins
Bugs vs. Drugs: How Our Microbiomes Can Explain Our Response to Statins
Drs. Serdar Turkarslan and Christian Diener

ISB Honors Researchers Who Give Back to STEM Education

This year, two deserving scientists were bestowed recognition for giving back to STEM education. Dr. Serdar Turkarslan is the recipient of the JoAnn Chrisman Award for Distinguished Service to STEM Education, and Dr. Christian Diener was awarded the Dr. Christine Schaeffer Award for Exemplary Service to STEM Education. 

ISB Honors Researchers Who Give Back to STEM Education
ISB Honors Researchers Who Give Back to STEM Education
1 10 11 12 13 14 34